Biography
Dr. Tommaso Pollini, M.D. is a post-doctoral research fellow at the University of California, San Francisco (UCSF) in the Maker Lab, specializing in pancreatic cystic neoplasms with a focus on Intraductal Papillary Mucinous Neoplasms (IPMN). He completed his surgical training at the Pancreas Institute of the University of Verona, Italy, where he developed a solid foundation in pancreatic diseases. Recognized for his contributions to the field, Dr. Pollini received the prestigious Kenneth Warren Fellowship from the International Hepato-Pancreato-Biliary Association and the Steve Sotsky Award from the American Hepato-Pancreato-Biliary Association.
At UCSF, his research centers on developing predictive models for high-grade dysplasia in pancreatic cystic tumors using machine learning. Utilizing his expertise in bioinformatics, single-nucleus RNA sequencing (snRNAseq), and spatial transcriptomics, he studies the tumor immune microenvironment of pancreatic cancers. Dr. Pollini has published his work in leading journals such as JAMA Surgery, The Lancet Gastroenterology & Hepatology, and Gastroenterology, contributing significantly to advancements in pancreatic cancer research.
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Kenneth Warren Fellowship | International Hepato-Pancreato-Biliary Association (IHPBA) | 2021/2022 |
Steve Sotksi Award | American Hepato-Pancreato-Biliary Association (AHPBA) | 2021 |
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of Verona | General Surgery Residency | 01/2023 | |
University of Verona | Research Fellow at the Department of General and Pancreatic Surgery of the Pancreas Institute | 12/2017 | |
University of Verona | MD | Medicine | 10/2015 |
Publications
- ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.| | PubMed
- ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.| | PubMed
- Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.| | PubMed
- Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis.| | PubMed
- Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis.| | PubMed
- Reply.| | PubMed
- Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages.| | PubMed
- "Mickey Mouse sign" to identify and remove cystic duct stones in postcholecystectomy syndrome.| | PubMed
- Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.| | PubMed
- Artificial intelligence-based models to assess the risk of malignancy on radiological imaging in patients with intraductal papillary mucinous neoplasm of the pancreas: scoping review.| | PubMed
- Concomitant Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm in Pancreatic Cysts-a Diagnostic and Surgical Dilemma.| | PubMed
- Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.| | PubMed
- It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy.| | PubMed
- Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections?| | PubMed
- The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.| | PubMed
- The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms.| | PubMed
- Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance.| | PubMed
- The use of a mobile application to disseminate guidelines on cystic neoplasms of the pancreas - A snapshot study of 1000 case-simulations.| | PubMed
- Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.| | PubMed
- The faith of non-surveilled pancreatic cysts: a bicentric retrospective study.| | PubMed
- Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.| | PubMed
- Serous Cystic Neoplasms of the Pancreas Management in the Real-world: Still Operating on a Benign Entity.| | PubMed
- Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.| | PubMed
- Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma.| | PubMed
- Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.| | PubMed
- Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery.| | PubMed
- "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?| | PubMed
- The management of intraductal papillary mucinous neoplasms of the pancreas.| | PubMed
- The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution.| | PubMed
- The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis.| | PubMed
- Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases.| | PubMed
- The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.| | PubMed
- Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results.| | PubMed
- Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas.| | PubMed
- Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series.| | PubMed
- Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center.| | PubMed
- Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies.| | PubMed